Conduent Q2 Earnings Call Highlights
Conduent (CNDT) reported Q2 results and 2026 guidance excluding discontinued transportation operations. Transportation revenue was $609M in 2025 with $18M EBITDA. The quarter ended with about $240M cash and negative adjusted free cash flow of $8M. Commercial revenue fell 13% to $316M; government revenue was $215M. 2026 revenue guidance is $2.15B-$2.25B and adjusted EBITDA $140M-$170M.
How this was made
The 30-second read
Why it matters
The key tradable update is the 2026 revenue and adjusted EBITDA range plus the stated drivers: cost-savings execution, government implementation timing, and commercial contract churn. Cash and adjusted free cash flow trends provide additional risk context for near-term financing and leverage expectations.
Market read
Traders can update 2026 earnings expectations using the revised guidance and weigh execution risks from commercial contract losses versus government implementation timing and cost-savings delivery.
What to watch
Commercial revenue fell 13% on contract losses and volume reductions, including the largest commercial client ending in Q3, which could pressure 2H results despite margin improvement from cost actions.
Background
The piece summarizes Conduent’s Q2 earnings call, including segment results, cost-savings progress, pipeline activity, AI initiatives, and a 2026 guidance revision tied to discontinued transportation operations.
Ticker impact
Conduent revised 2026 guidance to $2.15B-$2.25B revenue and $140M-$170M adjusted EBITDA, excluding discontinued transportation operations.
Likely supports a near-term re-rating if investors view the margin outlook as credible, but could face skepticism given commercial contract losses and negative adjusted FCF.
The article provides specific 2026 revenue and adjusted EBITDA ranges plus segment drivers (commercial decline, government timing) and cash/FCF context, which are direct inputs to valuation and positioning.
Market effects
Signals ongoing margin focus in business-process outsourcing via headcount and technology-stack optimization, with AI tooling as a differentiator.
Medicaid implementation timing (New Mexico early, Virginia expected in 2H 2026) highlights state-by-state execution risk in public-sector services.
Limited direct global spillover; mostly US healthcare and public-sector contract execution and divestiture effects.
Counterpoint
The guidance excludes discontinued transportation operations, so investors may discount comparability and focus on whether government implementation timing and commercial renewals can sustain margins.
Key entities
- companyConduent
Global business process services provider; subject of the earnings call highlights and 2026 guidance revision.
- personHarsha Agadi
CEO who discussed cost-savings composition, AI initiatives, and maintained the longer-term margin objective.
- customerSecurian
Named in a pension risk transfer administration engagement win.
- customerTrillium Health Resources
Named in a Health Services Plus platform agreement win.
- customerAvis Budget Group
Named in an expanded vehicle-citation offering win.
